Tomoko Nakajima

Company: Astellas Pharma

Job title: Executive Director

Seminars:

Panel Discussion: Clinical Advancements in Claudin-Targeted ADCs, Bispecifics, & CAR-T Therapies 11:00 am

Deep diving into the latest advancements and clinical outcomes of ADCs targeting Claudin 18.2 and Claudin 6, with a focus on engineering, payload optimization, and toxicity management specific to claudin targets Examining the role and efficacy of bispecific antibodies in enhancing the immune response against claudin-expressing tumors, supported by insights from preclinical and clinical data…Read more

day: Conference Day 1

Workshop: Mitigating Toxicity & Ensuring Safety in Claudin-Targeted Cancer Therapies 9:00 am

This workshop will focus on strategies to mitigate toxicity and enhance safety in Claudin-targeted therapies, addressing common side effects and preclinical profiling. Participants will learn about clinical trial designs and approaches to manage patient safety effectivelyRead more

day: Conference Day 2